RADIONUCLIDE BONE SCAN (LIMITED AREA)

DATE: 10/4/2005

PROCEDURE:  Following IV administration of technetium-99m methylenediphosphonate (MDP), planar images of the skeleton were obtained in the following views.

VIEWS:

RADIOPHARMACEUTICAL DOSE:  [25]  mCi

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with a history of [...]. The patient is referred for evaluation of possible osseous metastatic disease. The patient is referred for follow-up of osseous metastatic disease.

CORRELATIVE STUDIES: None.

COMPARISON: None.

FINDINGS:    There is increased tracer activity observed in [...] that are all consistent with degenerative changes.  The remainder of the axial and appendicular skeleton demonstrates normal tracer uptake. There is normal tracer activity in both kidneys and in the urinary bladder.

CONCLUSIONS:

There are no significant changes when compared to the prior study.

Normal study showing no evidence of osseous metastatic disease.

No focus of increased tracer uptake is identified that would be consistent with osseous metastasis.

Focally increased activity at the left 9th costovertebral angle also remains unchanged. Plain films done for these abnormalities described above with the prior examination were not suggestive for metastatic disease. Given stability and negative plain film findings, the likelihood of metastasis is exceedingly low.

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.